Monte Rosa Therapeutics, Inc. ($GLUE)
Filing Information
| Accession Number | 0001193125-26-282740 |
|---|---|
| Form Type | 4 |
| Filing Date | Jun 25, 2026 |
| Document | View SEC Filing |
Transactions
6
Total Shares
113,845
Total Value
$1,154,363.48
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chief Medical Officer | Common Stock | โ | Jun 23, 2026 | Exercise/Conversion | 6,000 | $7.56 | $45,360.00 | 71,837 | Direct | โ | View Details | |
Chief Medical Officer | Common Stock | โ | Jun 23, 2026 | Sale | 11,845 | $20.22 | $239,522.48 | 59,992 | Direct | โ | View Details | |
Chief Medical Officer | Common Stock | โ | Jun 24, 2026 | Exercise/Conversion | 30,000 | $7.56 | $226,800.00 | 89,992 | Direct | โ | View Details | |
Chief Medical Officer | Common Stock | โ | Jun 24, 2026 | Sale | 30,000 | $21.42 | $642,681.00 | 59,992 | Direct | โ | View Details | |
Chief Medical Officer | Stock Option (Right to Buy) | Derivative | Jun 23, 2026 | Exercise/Conversion | 6,000 | $0.00 | $0.00 | 96,000 | Direct | โ | View Details | |
Chief Medical Officer | Stock Option (Right to Buy) | Derivative | Jun 24, 2026 | Exercise/Conversion | 30,000 | $0.00 | $0.00 | 66,000 | Direct | โ | View Details |